Open AccessEfficacy and safety of propranolol in infants with heart failure due to moderate-to-large ventricular septal defect (VSD-PHF study) – A prospective randomized trial
Author(s) -
Sivasubramanian Ramakrishnan,
Nirmal Ghati,
Ramandeep Ahuja,
Kinjal Bhatt,
Hem Chandra Sati,
Anitá Saxena,
Shyam Sunder Kothari
Publication year - 2021
Publication title -
annals of pediatric cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 19
eISSN - 0974-2069
pISSN - 0974-5149
DOI - 10.4103/apc.apc_94_21
Subject(s) - medicine , clinical endpoint , propranolol , bronchospasm , randomized controlled trial , heart failure , adverse effect , prospective cohort study , cardiology , clinical trial , anesthesia , asthma
The utility of beta-blocker therapy in infants with heart failure (HF) due to significant left-to-right shunt lesions is not known. The study aimed to assess the efficacy and safety of propranolol in infants with HF due to moderate-to-large ventricular septal defect (VSD).